Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Call options for Human Genome Sciences jumped after the company rejected a buy offer from GlaxoSmithKline
On Air Now
Bloomberg Bottom Line
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC